Fovea ERM After Fovea-sparing ILM Peeling

Sponsor
Changhua Christian Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04445142
Collaborator
(none)
3
1
8
0.4

Study Details

Study Description

Brief Summary

To report cases who had received previous fovea-sparing internal limiting peeling membrane and developed secondary fovea epiretinal membrane contraction

Condition or Disease Intervention/Treatment Phase
  • Procedure: fovea-sparing internal limiting membrane peeling

Detailed Description

Purpose: To report the rare complication of foveal epiretinal membrane (ERM) formation on residual internal limiting membrane (ILM) with severe contraction after previous fovea-sparing internal limiting membrane (ILM) peeling.

Study design: Retrospective case series Methods: We report patients who previously received fovea-sparing ILM peeling and complicated with foveal ERM formation and contraction.

Study Design

Study Type:
Observational
Actual Enrollment :
3 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Severe Foveal Epiretinal Membrane Contraction After Previous Fovea-sparing Internal Limiting Membrane Peeling Surgery
Actual Study Start Date :
Sep 1, 2019
Actual Primary Completion Date :
Apr 30, 2020
Actual Study Completion Date :
Apr 30, 2020

Arms and Interventions

Arm Intervention/Treatment
epiretinal membrane group

Patients developed secondary fovea epiretinal membrane

Procedure: fovea-sparing internal limiting membrane peeling
fovea-sparing internal limiting membrane peeling surgery

Outcome Measures

Primary Outcome Measures

  1. Visual acuity [6 months]

    Snellen visual acuity change

  2. Optical coherence tomography finding [6 months]

    fovea change on optical coherence tomography

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • patients who developed secondary fovea epiretinal membrane after previous fovea-sparing internal limiting membrane surgery
Exclusion Criteria:
  • patients who did not receive previous fovea-sparing internal limiting membrane surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of ophthalmology, Changhua Christian Hospital Changhua City Taiwan 500

Sponsors and Collaborators

  • Changhua Christian Hospital

Investigators

  • Study Chair: San-Ni Chen, MD, Changhua Christian Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
San Ni Chen, Head of department of ophthalmology, Changhua Christian Hospital
ClinicalTrials.gov Identifier:
NCT04445142
Other Study ID Numbers:
  • 200402
First Posted:
Jun 24, 2020
Last Update Posted:
Jun 24, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by San Ni Chen, Head of department of ophthalmology, Changhua Christian Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 24, 2020